The financial firm have set target of GBX 1330.00 on Travis Perkins PLC (LON:TPK) shares. This is 7.19% from the stock close price. In an analyst report sent to investors on Thursday morning, Numis kept their Hold rating on shares of TPK.
Merit Medical Systems, Inc. designs, develops, makes, and markets medical products for interventional and diagnostic procedures worldwide. The company has market cap of $2.28 billion. The companyÂ’s Cardiovascular segment offers cardiology and radiology devices for diagnosing and treating coronary arterial, peripheral vascular, and other non-vascular diseases; and embolotherapeutic products. It has a 77.51 P/E ratio. It also provides vascular access products; guide wires, inflation devices, and diagnostic catheters for use in angiography procedures; therapeutic infusion systems and safety products; drainage catheters and drainage access products, support catheters, vascular retrieval devices, and dialysis access products; and embosphere microspheres and delivery systems, and microcatheters.
Timpani Capital Management Llc holds 2.33% of its portfolio in Merit Medical Systems, Inc. for 150,488 shares. Copper Rock Capital Partners Llc owns 692,153 shares or 1.95% of their US portfolio. Moreover, Eagle Boston Investment Management Inc has 1.86% invested in the company for 409,375 shares. The Massachusetts-based Aristotle Capital Boston Llc has invested 1.77% in the stock. Ami Asset Management Corp, a California-based fund reported 424,174 shares.
The stock decreased 2.99% or $1.4 during the last trading session, reaching $45.5. About 318,495 shares traded or 10.66% up from the average. Merit Medical Systems, Inc. (MMSI) has risen 81.84% since March 1, 2017 and is uptrending. It has outperformed by 65.14% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 3 sales for $517,063 activity.
The stock decreased 2.72% or GBX 35 during the last trading session, reaching GBX 1250. About 556,217 shares traded. Travis Perkins plc (LON:TPK) has 0.00% since March 1, 2017 and is . It has underperformed by 16.70% the S&P500.
Among 24 analysts covering Travis Perkins PLC (LON:TPK), 13 have Buy rating, 1 Sell and 10 Hold. Therefore 54% are positive. Travis Perkins PLC has GBX 2787 highest and GBX 2 lowest target. GBX 1824.10’s average target is 45.93% above currents GBX 1250 stock price. Travis Perkins PLC had 266 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Hold” rating by Peel Hunt given on Tuesday, August 2. The firm has “Buy” rating by Shore Capital given on Thursday, March 2. Goldman Sachs maintained the shares of TPK in report on Monday, November 23 with “Buy” rating. The rating was maintained by Peel Hunt on Thursday, October 19 with “Hold”. The rating was maintained by Deutsche Bank with “Buy” on Tuesday, April 19. The rating was maintained by Deutsche Bank with “Hold” on Thursday, October 22. On Friday, September 9 the stock rating was maintained by Goodbody with “Hold”. The company was maintained on Tuesday, January 19 by Deutsche Bank. The rating was maintained by Credit Suisse with “Outperform” on Wednesday, March 16. The firm earned “Buy” rating on Monday, July 11 by Deutsche Bank.
The post Travis Perkins PLC (LON:TPK) Investors: Numis Maintains Hold Rating, Sees GBX 1330.00/Share; Merit Medical Systems (MMSI)’s Sentiment Is 1.28 appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/03/01/travis-perkins-plc-lontpk-investors-numis-maintains-hold-rating-sees-gbx-1330-00-share-merit-medical-systems-mmsis-sentiment-is-1-28/
No comments:
Post a Comment